See more : Wally World Media, Inc. (WLYW) Income Statement Analysis – Financial Results
Complete financial analysis of Dian Diagnostics Group Co.,Ltd. (300244.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dian Diagnostics Group Co.,Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- MannKind Corporation (MNKD) Income Statement Analysis – Financial Results
- MSP Recovery, Inc. (MSPRV) Income Statement Analysis – Financial Results
- Onde S.A. (OND.WA) Income Statement Analysis – Financial Results
- Triveni Enterprises Limited (TRIVENIENT.BO) Income Statement Analysis – Financial Results
- Vital Farms, Inc. (VITL) Income Statement Analysis – Financial Results
Dian Diagnostics Group Co.,Ltd. (300244.SZ)
About Dian Diagnostics Group Co.,Ltd.
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.41B | 20.28B | 13.08B | 10.65B | 8.45B | 6.97B | 5.00B | 3.82B | 1.86B | 1.34B | 1.02B | 706.42M | 482.47M | 343.27M | 263.25M | 178.29M |
Cost of Revenue | 9.26B | 12.75B | 8.08B | 6.58B | 5.74B | 4.60B | 3.33B | 2.62B | 1.23B | 847.78M | 638.65M | 454.14M | 314.21M | 220.30M | 170.17M | 125.69M |
Gross Profit | 4.15B | 7.54B | 5.01B | 4.07B | 2.72B | 2.37B | 1.67B | 1.20B | 624.72M | 487.32M | 376.82M | 252.28M | 168.26M | 122.97M | 93.09M | 52.60M |
Gross Profit Ratio | 30.97% | 37.16% | 38.26% | 38.22% | 32.15% | 34.04% | 33.41% | 31.49% | 33.62% | 36.50% | 37.11% | 35.71% | 34.88% | 35.82% | 35.36% | 29.51% |
Research & Development | 432.64M | 638.47M | 424.75M | 319.10M | 211.91M | 166.27M | 131.96M | 101.16M | 78.18M | 57.01M | 33.35M | 22.55M | 10.66M | 0.00 | 0.00 | 0.00 |
General & Administrative | 180.35M | 270.88M | 227.78M | 205.66M | 196.05M | 187.39M | 167.38M | 118.53M | 74.15M | 55.71M | 44.10M | 32.72M | 28.43M | 53.20M | 43.82M | 21.15M |
Selling & Marketing | 574.34M | 1.60B | 1.21B | 966.37M | 760.77M | 648.65M | 464.18M | 326.83M | 164.11M | 134.38M | 115.84M | 79.11M | 50.17M | 33.43M | 24.10M | 16.45M |
SG&A | 2.68B | 1.87B | 1.44B | 1.17B | 956.83M | 836.04M | 631.56M | 445.35M | 238.27M | 190.09M | 159.94M | 111.83M | 78.60M | 86.63M | 67.92M | 37.60M |
Other Expenses | 201.23M | 961.48M | 861.91M | 564.86M | 464.44M | 12.68M | 36.58M | 19.10M | 16.30M | 2.70M | 3.62M | -3.03M | 2.70M | 4.11M | 718.16K | -477.66K |
Operating Expenses | 3.31B | 3.47B | 2.72B | 2.06B | 1.63B | 1.45B | 1.12B | 789.39M | 430.24M | 339.20M | 268.00M | 184.02M | 125.54M | 88.04M | 70.40M | 42.25M |
Cost & Expenses | 12.57B | 16.21B | 10.80B | 8.63B | 7.37B | 6.04B | 4.45B | 3.41B | 1.66B | 1.19B | 906.65M | 638.16M | 439.75M | 308.34M | 240.57M | 167.94M |
Interest Income | 29.15M | 20.83M | 22.13M | 19.45M | 16.53M | 604.92K | 1.51M | 4.18M | 1.94M | 3.93M | 4.97M | 7.76M | 4.54M | 444.49K | 243.89K | 121.61K |
Interest Expense | 250.60M | 274.73M | 230.20M | 206.82M | 219.90M | 170.33M | 112.83M | 37.06M | 20.85M | 895.77K | 2.49M | 2.19M | 471.62K | 1.34M | 2.86M | 2.80M |
Depreciation & Amortization | 791.97M | 888.64M | 569.90M | 365.69M | 304.42M | 231.09M | 154.78M | 79.98M | 38.14M | 26.99M | 19.69M | 12.74M | 8.99M | 6.64M | 5.52M | 4.04M |
EBITDA | 1.86B | 3.70B | 2.52B | 1.88B | 1.24B | 1.08B | 846.29M | 512.23M | 260.42M | 180.19M | 133.84M | 88.19M | 58.45M | 45.84M | 28.35M | 13.31M |
EBITDA Ratio | 13.87% | 22.75% | 21.32% | 22.25% | 17.04% | 17.03% | 18.15% | 14.12% | 14.68% | 13.79% | 13.37% | 12.86% | 12.18% | 13.42% | 11.06% | 7.77% |
Operating Income | 842.18M | 3.81B | 1.84B | 2.08B | 1.19B | 721.40M | 592.90M | 415.85M | 194.54M | 150.22M | 108.23M | 71.60M | 46.42M | 33.86M | 19.27M | 6.97M |
Operating Income Ratio | 6.28% | 18.81% | 14.05% | 19.50% | 14.11% | 10.35% | 11.85% | 10.87% | 10.47% | 11.25% | 10.66% | 10.14% | 9.62% | 9.86% | 7.32% | 3.91% |
Total Other Income/Expenses | -43.86M | -279.05M | -46.94M | -2.92M | -3.40M | 12.68M | -15.14M | -21.17M | -8.88M | 2.09M | 3.42M | 7.02M | 2.56M | 3.04M | -2.00M | -3.36M |
Income Before Tax | 798.33M | 2.54B | 1.79B | 1.32B | 771.17M | 734.07M | 629.49M | 434.35M | 210.46M | 152.31M | 111.65M | 73.26M | 48.99M | 37.86M | 19.96M | 6.47M |
Income Before Tax Ratio | 5.95% | 12.54% | 13.69% | 12.37% | 9.12% | 10.54% | 12.58% | 11.36% | 11.33% | 11.41% | 10.99% | 10.37% | 10.15% | 11.03% | 7.58% | 3.63% |
Income Tax Expense | 216.74M | 681.09M | 307.40M | 247.46M | 195.61M | 145.61M | 165.39M | 96.40M | 31.67M | 24.46M | 21.62M | 13.87M | 7.41M | 7.95M | 4.74M | 1.97M |
Net Income | 307.46M | 1.43B | 1.16B | 802.93M | 575.57M | 388.61M | 349.59M | 262.76M | 174.79M | 124.58M | 86.09M | 60.19M | 42.21M | 32.41M | 17.17M | 6.59M |
Net Income Ratio | 2.29% | 7.07% | 8.89% | 7.54% | 6.81% | 5.58% | 6.99% | 6.87% | 9.41% | 9.33% | 8.48% | 8.52% | 8.75% | 9.44% | 6.52% | 3.70% |
EPS | 0.50 | 2.30 | 1.87 | 1.29 | 0.93 | 0.71 | 0.64 | 0.48 | 0.36 | 0.26 | 0.18 | 0.13 | 0.10 | 0.10 | 0.06 | 0.03 |
EPS Diluted | 0.49 | 2.30 | 1.87 | 1.29 | 0.93 | 0.71 | 0.64 | 0.48 | 0.36 | 0.26 | 0.18 | 0.13 | 0.10 | 0.10 | 0.06 | 0.03 |
Weighted Avg Shares Out | 619.45M | 622.97M | 620.46M | 620.46M | 620.46M | 547.34M | 546.24M | 547.42M | 485.54M | 477.13M | 479.63M | 478.82M | 404.22M | 338.99M | 266.36M | 235.92M |
Weighted Avg Shares Out (Dil) | 625.18M | 624.02M | 620.46M | 620.46M | 620.46M | 547.34M | 546.24M | 547.42M | 485.54M | 487.50M | 479.66M | 478.85M | 404.22M | 338.99M | 266.36M | 235.92M |
Source: https://incomestatements.info
Category: Stock Reports